DRTS
Alpha Tau Medical Ltd.
$3.90
+$0.25(+6.85%)
20
Overall
--
Value
20
Tech
--
Quality
Market Cap
$259.00M
Volume
101.99K
52W Range
$2.30 - $4.69
Target Price
$8.67
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $13.8M | $32.1M | $35.7M | $36.0M | ||
| Research & Development | $11.4M | $20.9M | $26.4M | $27.0M | ||
| Research Expense | $11.4M | $20.9M | -- | -- | ||
| Selling, General & Administrative | $2.3M | $11.2M | $9.3M | $9.0M | ||
| Selling & Marketing Expenses | $482.0K | $974.0K | $1.9M | $2.3M | ||
| General & Administrative Expenses | $1.9M | $10.3M | $7.3M | $6.7M | ||
| Salaries & Wages | $-812.0K | $-16.3M | -- | -- | ||
| Depreciation & Amortization | $-776.0K | $-7.5M | -- | -- | ||
| Depreciation & Amortization | $-776.0K | $-7.5M | -- | -- | ||
| Other Operating Expenses | -- | $-775.0K | $39.0K | -- | ||
| OPERATING INCOME | ||||||
| Operating income | $-13.8M | $-32.1M | $-35.7M | $-36.0M | ||
| EBITDA | $28.0M | $-32.8M | $-41.1M | $-30.6M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | -- | -- | $75.0K | -- | ||
| Interest Income Operating | $211.0K | $1.8M | -- | -- | ||
| Intinc | -- | -- | $-6.5M | $4.3M | ||
| Net Non-Operating Interest Income/Expense | -- | -- | $-6.5M | $4.3M | ||
| Gain on Sale of Securities | -- | $51.3M | -- | -- | ||
| Other Income/Expense | $-13.5M | $1.6M | $1.8M | -- | ||
| Other Special Charges | $13.5M | $-1.6M | -- | -- | ||
| SPECIAL ITEMS | ||||||
| Other Impairment Of Capital Assets | -- | $-54.0K | -- | -- | ||
| PRE-TAX INCOME | ||||||
| EBIT | $27.3M | $-33.7M | $-42.2M | $-31.7M | ||
| Pre-Tax Income | $27.3M | $-33.7M | $-42.2M | $-31.7M | ||
| INCOME TAX | ||||||
| Tax Provision | $-7.0K | $20.0K | $-16.0K | $6.0K | ||
| NET INCOME | ||||||
| Net Income | $-309.0K | $-33.8M | $-42.2M | $-31.8M | ||
| Net Income (Continuing Operations) | $-309.0K | $-33.8M | $-42.2M | $-31.8M | ||
| Net Income (Discontinued Operations) | $-309.0K | $-33.8M | $-42.2M | $-31.8M | ||
| Net Income (Common Stockholders) | $-309.0K | $-33.8M | $-42.2M | $-31.8M | ||
| Normalized Income | -- | -- | $-42.2M | $-31.4M | ||
| TOTALS | ||||||
| Total Expenses | $13.8M | $32.1M | $35.7M | $36.0M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $40.5M | $63.5M | $69.4M | $69.9M | ||
| Average Shares Outstanding (Diluted) | $40.5M | $63.5M | $69.4M | $69.9M | ||
| Shares Outstanding | $120.8M | $69.1M | $70.4M | $70.4M | ||
| Basic EPS | $-0.67 | $-0.53 | $-0.42 | $-0.45 | ||
| Basic EPS (Continuing Operations) | $-0.67 | $-0.53 | $-0.42 | $-0.45 | ||
| Diluted EPS | $-0.67 | $-0.53 | $-0.42 | $-0.45 | ||
| Diluted EPS (Continuing Operations) | $-0.67 | $-0.53 | $-0.42 | $-0.45 | ||
| OTHER METRICS | ||||||
| Marketing Expense | $482.0K | $974.0K | $1.9M | $2.3M | ||
| Other Gand A | $1.9M | $10.3M | $7.3M | $6.7M | ||
| Rent And Landing Fees | $1.9M | $10.3M | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DRTS | $3.90 | +6.8% | 101.99K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |